Highlights of This Issue
March 2011
in “
Cancer Epidemiology Biomarkers & Prevention
”
TLDR SLCO genes may predict prostate cancer mortality risk, and lifestyle changes improve health in advanced prostate cancer.
The document highlighted several studies related to cancer research. Wright et al. found that increased expression of SLCO genes in castration-resistant prostate cancer (CRPC) metastases was associated with a higher risk of prostate cancer-specific mortality, suggesting these genes as potential biomarkers. Kapp et al. reported racial/ethnic differences in mammography behavior, with Hispanic women less likely to have future screenings and African American women more likely to delay them. Kristal et al. found no association between lycopene and reduced prostate cancer risk. Bourke et al. demonstrated that a lifestyle intervention involving exercise and dietary advice improved health outcomes in men with advanced prostate cancer undergoing androgen suppression therapy.